I think £3,000 invested in these 3 FTSE 100 stocks could help you retire early

These FTSE 100 stocks could take care of your retirement decisions and leave you free to focus on everyday life, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We’re facing the worst global pandemic in a 100 years. The stock market has crashed, leaving some FTSE 100 stocks down by as much as 50%. In this situation, working out where to put your retirement savings is pretty difficult.

To solve this problem, I prefer to invest in companies that provide essential products and services. The kind of thing we can’t do without. In this piece I’m going to look at three firms which I rate as buys in today’s market.

Healthcare should deliver long-term growth

My first pick is FTSE 100 pharmaceutical group GlaxoSmithKline (LSE: GSK). This may seem an obvious choice in the coronavirus pandemic, but in reality I don’t think this crisis will have much impact on Glaxo.

The group’s boffins are working with peers at French firm Sanofi to develop a vaccine for Covid-19. But even if this is successful, it will only be one of many vaccines sold by GlaxoSmithKline, which is heavily invested in this sector.

As well as vaccines, the Brentford-based group also specialises in treatments for respiratory illnesses, HIV, and cancer. Glaxo also has a large portfolio of branded consumer healthcare products such as Sensodyne and Panadol.

I expect this FTSE 100 stock to deliver reliable growth for decades to come. At current levels, the shares offer a dividend yield of 4.8% and trade on around 14 times forecast earnings. I’d like to buy more at this level.

This FTSE 100 stock looks too cheap

A long-term holding in my own portfolio is FTSE 100 insurer Aviva (LSE: AV). This insurance and savings group paid out £33bn in claims in 2019 and ended the year with more than £500bn of assets under management.

Aviva has been in business for more than 320 years. As you can see from the numbers above, it’s a pretty large business. I’m pretty confident that products such as home and life insurance will remain important to us in the future.

Unfortunately the group has suspended its dividend, following pressure on insurers from the UK’s financial regulator.

However, Aviva reported a capital surplus of £12.6bn at the end of 2019. I’m fairly comfortable the company will be able to absorb extra losses resulting from the pandemic. I expect the dividend to return fairly quickly.

The market crash has left Aviva stock trading at a 45% discount to its 2019 net asset value of 434p. I think that’s too cheap and rate this FTSE 100 stock as long-term buy.

A great British engineer

Smiths Group (LSE: SMIN) has featured in the news recently as a supplier of ventilators to the NHS. But this business is an old-fashioned engineering conglomerate which operates in a number of sectors.

In addition to medical equipment, Smiths makes products including airport security scanners, flexible hoses, and electronics. The group also provides specialist seals and filtration systems used in sectors including oil and gas and chemicals.

Some of these businesses could see a slump in demand over the next year or two, in my opinion. But Smiths’ latest results show the group performing well during the six months to 31 January, with half-year profits up by 17%.

Smiths shares haven’t traded at current levels since 2016. I see this as a good opportunity to buy into a successful industrial group which has evolved over more than 100 years. The shares look reasonably priced to me, on around 15 times forecast earnings.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of Aviva and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »